之江生物(688317.SH)：第三季度净亏损1952.69万

Core Viewpoint - Zhijiang Biology (688317.SH) reported a significant decline in revenue and net profit for Q3 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for Q3 2025 was 30.75 million yuan, representing a year-on-year decrease of 28.46% [1] - The net profit attributable to shareholders of the listed company was -19.53 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -24.00 million yuan [1]